<code id='36D3A76DF4'></code><style id='36D3A76DF4'></style>
    • <acronym id='36D3A76DF4'></acronym>
      <center id='36D3A76DF4'><center id='36D3A76DF4'><tfoot id='36D3A76DF4'></tfoot></center><abbr id='36D3A76DF4'><dir id='36D3A76DF4'><tfoot id='36D3A76DF4'></tfoot><noframes id='36D3A76DF4'>

    • <optgroup id='36D3A76DF4'><strike id='36D3A76DF4'><sup id='36D3A76DF4'></sup></strike><code id='36D3A76DF4'></code></optgroup>
        1. <b id='36D3A76DF4'><label id='36D3A76DF4'><select id='36D3A76DF4'><dt id='36D3A76DF4'><span id='36D3A76DF4'></span></dt></select></label></b><u id='36D3A76DF4'></u>
          <i id='36D3A76DF4'><strike id='36D3A76DF4'><tt id='36D3A76DF4'><pre id='36D3A76DF4'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:274

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Listen: Vivek Ramaswamy's star turn & leaky drug data
          Listen: Vivek Ramaswamy's star turn & leaky drug data

          Doesbiotechprepareyouforthepresidency?WhoreallywantstoguttheFDA?AndwhydodrugcompaniesstrugglewithIT?

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Drugmakers bet big on mRNA for cancer. Why's Biden going in?

          DrugmakersalreadybetbigonmRNAforcancer.NowPresidentBidenisgoingin,too?AnnaMoneymaker/GettyImagesWASH